US 7446108
Tri-and tetraaza-acenaphthylen derivatives as CRF receptor antagonists
granted A61PA61P1/00A61P1/04
Quick answer
US patent 7446108 (Tri-and tetraaza-acenaphthylen derivatives as CRF receptor antagonists) held by Neurocrine, Inc. expires Mon Oct 30 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Neurocrine, Inc.
- Grant date
- Tue Nov 04 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 30 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 5
- CPC classes
- A61P, A61P1/00, A61P1/04, A61P25/00, A61P25/20